Recent Press Releases

Amgen Scholars Undergraduate Summer Research Program Begins Phase 2

Eight-Year, $34 Million Program, in Partnership with 13 Top Universities, Will Reach Nearly 2,500 UndergraduatesTHOUSAND OAKS, Calif., Nov. 10, 2010 /PRNewswire/ -- Today, Amgen Scholars, the

Driven by the Uptake of Several Emerging Agents, the MRSA Drug Market Will Increase From $631 Million in 2009 to $752 Million in

Key Emerging Agents That Will Drive Growth Include Ceftaroline and Torezolid, According to Findings from Decision ResourcesBURLINGTON, Mass., Nov. 10, 2010 /PRNewswire/ -- Decision Resources, one of

Pharmaceutical Company Lawyer Charged with Obstruction and Making False Statements

WASHINGTON - An attorney for a major pharmaceutical company was charged with obstruction and making false statements, the Justice Department announced today. Lauren Stevens of Durham, N.C., was

Perrigo Company to Present at the Credit Suisse Annual Health Care Conference

ALLEGAN, Mich., Nov. 10, 2010 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that Perrigo Chairman and CEO Joseph C. Papa will present at the Credit Suisse Annual

Watson’s Eden Biodesign and Crucell Sign Vendor Network Agreement Facilitating Access to cGMP Manufacturing Services for V

LIVERPOOL, United Kingdom & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Eden Biodesign Ltd. today announced the execution of a non-exclusive Vendor Network Agreement with Crucell, under which

Giving Thanks and Eating Well: F.A.C.E. Diabetes and Anthony Anderson Encourage African Americans to 'Make Over Your Sunday Meal

Actor/comedian to emphasize the importance of healthy recipes for Sunday suppers and ThanksgivingNEW YORK, Nov. 10, 2010 /PRNewswire/ -- In recognition of November as National Diabetes Awareness

Lower Protein in Infant Formula Supports Growth Rate Similar to Breast Milk, New Study Shows

MADISON, N.J., Nov. 10, 2010 /PRNewswire-FirstCall/ -- Newly published findings indicate that infants fed a lower protein infant formula developed by Pfizer Nutrition gained weight at a similar rate

Amgen to Present at 19th Annual Credit Suisse Healthcare Conference

THOUSAND OAKS, Calif., Nov. 9, 2010 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) will participate in the 19th Annual Credit Suisse Healthcare Conference on Friday, Nov. 12, 2010, at the Biltmore

Merck Wins TEMODAR® Patent Infringement Lawsuit on Appeal

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck & Co., Inc. said today that a federal appellate court ruled in its favor in a TEMODAR patent infringement suit against Barr Laboratories, an

Teva to Present at the Credit Suisse 2010 Healthcare Conference

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the Credit Suisse 2010 Healthcare Conference with William Marth, President & CEO,

Genzyme Responds to Sanofi-Aventis Letter

Genzyme Responds to Sanofi-Aventis LetterReiterates Board's Unanimous Position that $69 Offer is Not Appropriate Starting Point for Discussions CAMBRIDGE, Mass., Nov 08, 2010 (BUSINESS WIRE) --

Alpine Mountaineer and Alzheimer's Advocate to Climb Highest Peak on Each Continent to Raise Awareness of Growing Prevalence and

- Alan Arnette, Caregiver to His Mother, Now Dedicates Challenging Climbs to Her Memory and Others Caring for Alzheimer's Patients -NEW YORK, Nov. 9, 2010 /PRNewswire/ -- Alpine mountaineer and

Korean Biotechnology Leader AnyGen Launches the Highest Purity Custom-Made and Catalog Peptides in the U.S. Market

Korean Biotechnology Leader AnyGen Launches the Highest Purity Custom-Made and Catalog Peptides in the U.S. Market Korean Biotechnology leader AnyGen is launching its high-level custom-made and

APP Pharmaceuticals to Launch Drug Hotline

APP Pharmaceuticals to Launch Drug HotlineProvides Healthcare Professionals with Up-to-Date Drug Shortage Information SCHAUMBURG, Ill., Nov 05, 2010 (BUSINESS WIRE) -- APP Pharmaceuticals, Inc., a

MonoSol Rx Issued Strategic U.S. Patent Governing the Manufacturing of Pharmaceutical Films

MonoSol Rx Issued Strategic U.S. Patent Governing the Manufacturing of Pharmaceutical Films Covers PharmFilm® Technology methods of making self-supporting therapeutic active-containing

Systech International and Vantage Consulting Group Partner to Address Emerging U.S. Pharmaceutical Regulatory Requirements

Systech International and Vantage Consulting Group Partner to Address Emerging U.S. Pharmaceutical Regulatory Requirements Vantage Consulting Group (VCG) will sell, install and support Systech's

Celanese Launches VitalDose(TM) Controlled-Release Excipient for the Pharmaceutical Industry

Celanese Launches VitalDose(TM) Controlled-Release Excipient for the Pharmaceutical Industry DALLAS, Nov 05, 2010 (BUSINESS WIRE) -- Celanese Corporation, a global technology and specialty

Celgene Corporation to Present at Two Upcoming Investor Conferences

SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ: CELG) today announced its presentations at two upcoming investor conferences will be webcast live and will be available in the investor

NOVAVAX Awarded Nearly $1 Million in Grants from IRS Under Qualifying Therapeutic Discovery Project

ROCKVILLE, Md., Nov. 4, 2010 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that it has been awarded approximately $978,000 in grants under the Internal Revenue Service's Qualifying

Incyte Reports Third Quarter 2010 Financial Results and Provides Update on Drug Discovery and Development Programs

Phase I/II Data for INCB18424 in Myelofibrosis Published in the New England Journal of MedicineSPA Secured, Phase III Trial Initiated for INCB18424 in Polycythemia Vera and $50 Million in Milestones